HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trends in mortality from sporadic Creutzfeldt-Jakob disease in France 1992-7.

Abstract
This study examined trends in mortality from sporadic Creutzfeldt-Jakob disease in France for 1992-7 by age, genotype at the codon 129 of the prion protein gene, and geographical area. Case ascertainment was based on notifications by neurologists, neuropathologists, and laboratories; 324 deaths from definite or probable Creutzfeldt-Jakob disease were registered during the study period. The yearly number of deaths increased significantly between 1992 and 1997. The rise was higher for older age groups. It was also higher in those who were homozygous for valine compared with other genotypes. Eighteen departments (geographical administrative areas) out of 95 showed a significant increase in the number of deaths from sporadic Creutzfeldt-Jakob disease. Intensive epidemiological surveillance is a likely explanation for the apparent increase in the number of sporadic cases of Creutzfeldt-Jakob disease over the 1992-7 period, particularly in older age groups and in departments with low mortality rate at the beginning of the study period. Intensive surveillance may also have led to a better identification of atypical valine homozygous cases.
AuthorsJ H d'Aignaux, J L Laplanche, N Delasnerie-Lauprêtre, J P Brandel, K Peoc'h, D Salomon, J J Hauw, A Alpérovitch
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 68 Issue 6 Pg. 787-9 (Jun 2000) ISSN: 0022-3050 [Print] England
PMID10811709 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon
  • Prions
  • Methionine
  • Valine
Topics
  • Aged
  • Aged, 80 and over
  • Cause of Death (trends)
  • Codon
  • Creutzfeldt-Jakob Syndrome (diagnosis, genetics, mortality)
  • Cross-Sectional Studies
  • France (epidemiology)
  • Genotype
  • Humans
  • Incidence
  • Methionine (genetics)
  • Middle Aged
  • Prions (genetics)
  • Valine (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: